| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |